• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU

NEUREN PHARMACEUTICALS LIMITED

5.97% ! $11.01
Market Cap $1.387B  !

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NEU
NEU chart
37 38 39
23/04/25 2.2K 1.2M
23/04/25 Last post  Saragian Comments Created with Sketch.  2.2K  Views Created with Sketch.  1.2M 
NEU
Phase out of Red dye
23/04/25 3 632
23/04/25 Last post  baldwidx Comments Created with Sketch.  3  Views Created with Sketch.  632 
NEU
Share Price
23/04/25 15K 7.2M
Metals & Mining SECTOR NEWS

More Strong Drilling Results for Apollo Hill Gold Project

STN
23 Apr 2025
SATURN METALS LIMITED
23/04/25 Last post  Anydaynow Comments Created with Sketch.  15K  Views Created with Sketch.  7.2M 
NEU 23/04/25 4 1.8K
23/04/25 Last post  Rgupta11in Comments Created with Sketch.  4  Views Created with Sketch.  1.8K 
NEU
Neuren Media and Analyst Coverage
25 26 27
22/04/25 1.5K 899K
22/04/25 Last post  geffa9 Comments Created with Sketch.  1.5K  Views Created with Sketch.  899K 
NEU 22/04/25 160 73K
22/04/25 Last post  htae39 Comments Created with Sketch.  160  Views Created with Sketch.  73K 
NEU 22/04/25 0 617
22/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  617 
NEU
The Pill Penalty
18/04/25 0 930
18/04/25 Last post  hottod Comments Created with Sketch.  0  Views Created with Sketch.  930 

See All Discussions arrow Created with Sketch.

Timeline

Update - Notification of buy-back - NEU
23 Apr 07:59
 
Update - Notification of buy-back - NEU
22 Apr 08:42
 
Update - Notification of buy-back - NEU
17 Apr 08:36
 
Change of Director's Interest Notice - J Basile
16 Apr 16:52
 
NEU confirms primary endpoints for Phase 3 trial in PMS
14 Apr 08:58
 
Update - Notification of buy-back - NEU
07 Apr 08:26
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$11.01
Change
0.620(5.97%)
Mkt cap ! $1.387B
Open High Low Value Volume
$10.81 $11.27 $10.61 $6.056M 550.5K

Buyers (Bids)

No. Vol. Price($)
2 2347 $10.96
 

Sellers (Offers)

Price($) Vol. No.
$11.06 6035 2
View Market Depth
Last trade - 16.10pm 23/04/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.